128 related articles for article (PubMed ID: 3607752)
1. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
Lundberg B
Cancer Res; 1987 Aug; 47(15):4105-8. PubMed ID: 3607752
[TBL] [Abstract][Full Text] [Related]
2. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
Vitols S
Cancer Cells; 1991 Dec; 3(12):488-95. PubMed ID: 1840290
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells.
Lestavel-Delattre S; Martin-Nizard F; Clavey V; Testard P; Favre G; Doualin G; Houssaini HS; Bard JM; Duriez P; Delbart C
Cancer Res; 1992 Jul; 52(13):3629-35. PubMed ID: 1617635
[TBL] [Abstract][Full Text] [Related]
4. Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
Koller-Lucae SK; Schott H; Schwendener RA
Br J Cancer; 1999 Jul; 80(10):1542-9. PubMed ID: 10408395
[TBL] [Abstract][Full Text] [Related]
5. [Targeting of tumor cells by low density lipoproteins: principle and use of ellipticin derivatives].
Favre G
C R Seances Soc Biol Fil; 1992; 186(1-2):73-87. PubMed ID: 1450992
[TBL] [Abstract][Full Text] [Related]
6. Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway.
Rudling MJ; Collins VP; Peterson CO
Cancer Res; 1983 Oct; 43(10):4600-5. PubMed ID: 6309372
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.
Masquelier M; Vitols S; Peterson C
Cancer Res; 1986 Aug; 46(8):3842-7. PubMed ID: 3731059
[TBL] [Abstract][Full Text] [Related]
8. Modulation of low density lipoprotein receptor activity in squamous carcinoma cells by variation in cell density.
Vermeer BJ; Wijsman MC; Mommaas-Kienhuis AM; Ponec M; Havekes L
Eur J Cell Biol; 1985 Sep; 38(2):353-60. PubMed ID: 3899647
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells.
Masquelier M; Lundberg B; Peterson C; Vitols S
Leuk Res; 2006 Feb; 30(2):136-44. PubMed ID: 16085310
[TBL] [Abstract][Full Text] [Related]
10. [Vectorization of antineoplastic drugs by low density lipoproteins: incorporation of acyl celiptium and metabolism of complexes in the cellular receptor of human fibroblasts].
Samadi-Baboli M; Favre G; Soula G
Bull Cancer; 1989; 76(8):853-7. PubMed ID: 2620112
[No Abstract] [Full Text] [Related]
11. Cytotoxic activity of two new lipophilic steroid nitrogen carbamates incorporated into low-density lipoprotein.
Lundberg B
Anticancer Drug Des; 1994 Oct; 9(5):471-6. PubMed ID: 7945729
[TBL] [Abstract][Full Text] [Related]
12. Native and acetylated low density lipoprotein metabolism in proliferating and quiescent bovine endothelial cells in culture.
Sanan DA; Strümpfer AE; van der Westhuyzen DR; Coetzee GA
Eur J Cell Biol; 1985 Jan; 36(1):81-90. PubMed ID: 3979404
[TBL] [Abstract][Full Text] [Related]
13. Bunazosin enhances receptor-mediated endocytosis of low-density lipoproteins.
Matsunaga A; Hidaka K; Sasaki J; Arakawa K
Artery; 1992; 19(6):307-17. PubMed ID: 1361724
[TBL] [Abstract][Full Text] [Related]
14. Prolonged serum half-life of antineoplastic drugs by incorporation into the low density lipoprotein.
de Smidt PC; van Berkel TJ
Cancer Res; 1990 Dec; 50(23):7476-82. PubMed ID: 2147578
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
16. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
[TBL] [Abstract][Full Text] [Related]
17. [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells].
Li W; Xi S; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):636-8. PubMed ID: 16200711
[TBL] [Abstract][Full Text] [Related]
18. The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway.
Scharnagl H; Tisljar U; Winkler K; Hüttinger M; Nauck MA; Gross W; Wieland H; Ohm TG; März W
Lab Invest; 1999 Oct; 79(10):1271-86. PubMed ID: 10532590
[TBL] [Abstract][Full Text] [Related]
19. Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways.
Sqalli-Houssaini H; Pierlot C; Kusnierz JP; Parmentier B; Martin-Nizard F; Lestavel-Delattre S; Tartar A; Fruchart JC; Sergheraert C; Duriez P
Biotechnol Ther; 1994; 5(1-2):69-85. PubMed ID: 7703834
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
Tertov VV; Orekhov AN
Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
